Virchows Archiv

, Volume 457, Issue 5, pp 529–536 | Cite as

Immunohistochemical analysis of pyloric gland adenomas using a series of Mucin 2, Mucin 5AC, Mucin 6, CD10, Ki67 and p53

  • Michael Vieth
  • Ryoji Kushima
  • Ken-ichi Mukaisho
  • Rie Sakai
  • T. Kasami
  • Takanori Hattori
Original Article


A pyloric gland adenoma (PGA) of the stomach was first described in a book chapter in 1976 by Kurt Elster and has been rarely reported in the literature. We expanded the current immunohistochemical data of these adenomas in a detailed series to further analyse the immunhistochemical status of PGA. From 60 patients with PGA with and without adenocarcinomas of the gastrointestinal tract, an immunhistochemical panel of Mucin 2, Mucin 5AC, Mucin 6, CD10, Ki67 and p53 was used to define the expression of these markers. All PGA were positive for Mucin 6 (deep mucoid glands), which they express over the whole lesion up to the surface. Mucin 5AC expression varies from case to case. A transition from gastric to intestinal differentiation can be observed focally as depicted by Mucin 2 and CD10 in 65% of the cases. The gastric corpus mucosa of elderly patients with either Helicobacter pylori gastritis or autoimmune gastritis is highly affected. Almost 47% of all PGA already underwent malignant transformation into adenocarcinoma. Significant immunohistochemical differences could be detected between PGA with and without adenocarcinoma regarding ki67 and p53. The diagnosis of PGA can be confirmed immunohistochemically by staining against apomucin 6 and apomucin 5AC. Focal intestinal differentiation supports the hypothesis that gastric adenocarcinomas can initially develop from carcinomas of the gastric type and transform into intestinal type later on. The high frequency of malignant transformation of PGA underlines its high potential for invasive malignancy.


Pyloric gland adenoma Immunohistochemistry Adenocarcinoma Gastro-intestinal tract 



This manuscript is dedicated to Professor Manfred Stolte on occasion of his 70th birthday. The authors declare no conflict of interest.


  1. 1.
    Eidt S, Stolte M (1989) Gastric glandular cysts–investigations into their genesis and relationship to colorectal epithelial tumors. Z Gastroenterol 27:212–7PubMedGoogle Scholar
  2. 2.
    Oberhuber G, Stolte M (2000) Gastric polyps: an update of their pathology and biological significance. Virchows Arch 437:581–590CrossRefPubMedGoogle Scholar
  3. 3.
    Kushima R, Müller W, Stolte M, Borchard F (1996) Differential p53 protein expression in gastric adenomas of gastric and intestinal types: possible sequence of p53 alteration in the stomach carcinogenesis according to histological and mucin histochemical phenotypes. Virchows Arch 428:223–227PubMedGoogle Scholar
  4. 4.
    Hamilton SR, Aaltonen LA (eds) (2000) WHO classification of tumours. Tumours of the digestive system. IARC, LyonGoogle Scholar
  5. 5.
    Borchard F, Ghanei A, Koldovsky U, Hengels KJ, Bückmann FW (1990) Gastrale Differenzierung in Adenomen der Magenschleimhaut Immunhistochemische und elektronenmikroskopische Untersuchungen. Verh Dtsch Ges Pathol 74:528Google Scholar
  6. 6.
    Kato N, Akiyama S, Motoyama T (2002) Pyloric gland-type tubular adenoma superimposed on intraductal papillary mucinous tumor of the pancreas. Pyloric gland adenoma of the pancreas. Virchows Arch 440:205–8CrossRefPubMedGoogle Scholar
  7. 7.
    Watanabe H, Gass JF, Sobin LH (1990) Histological typing of oesophageal and gastric tumours. Spinger, BerlinGoogle Scholar
  8. 8.
    Elster K (1976) Histologic classification of gastric polyps. In: Morson BC (ed) Pathology of the gastro-intestinal tract. Springer, Berlin, pp 78–92Google Scholar
  9. 9.
    Borchard F (1987) 16. Tutorial IAP, Tumoren des oberen Gastrointestinaltraktes, DüsseldorfGoogle Scholar
  10. 10.
    Kushima R, Rüthlein HJ, Stolte M, Hattori T, Borchard F (1999) Pyloric gland-type adenoma arising in heterotopic gastric mucosa of the duodenum with dysplastic progression of the gastric type. Virch Arch 435:452–7CrossRefGoogle Scholar
  11. 11.
    Bakotic BW, Robinson MJ, Sturm PD, Hruban RH, Offerhaus GJ, Albores-Saavedra J (1999) Pyloric gland adenoma of the main pancreatic duct. Am J Surg Pathol 23:227–231CrossRefPubMedGoogle Scholar
  12. 12.
    Itoi T, Watanabe H, Ajioka Y, Ooohashi Y, Takei K, Nishikura K, Nakamura Y, Horic A, Saito T (1996) APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis. Pathol Int 46:333–340CrossRefPubMedGoogle Scholar
  13. 13.
    Kushima R, Remmele W, Stolte M, Borchard F (1996) Pyloric gland type adenoma of the gallbladder with squamoid spindle cell metaplasia. Pathol Res Pract 192:963–969PubMedGoogle Scholar
  14. 14.
    Takei K, Watanabe H, Itoi T, Saito T (1996) p53 and Ki-67 immunoreactivity and nuclear morphometry of "carcinoma-in-adenoma" and adenoma of the gall bladder. Pathol Int 46:908–917CrossRefPubMedGoogle Scholar
  15. 15.
    Michal M, Crurik R, Matler K, Benes Z (2003) Regarding the paper by Vieth et al. Virchows Archiv 443/4:317-321. Virchows Archiv 443:589–590Google Scholar
  16. 16.
    Ishii K, Hidaka E, Katsuyama T, Ota H, Shiozawa T, Tsuchiya S (1999) Ultrastructural features of adenoma malignum of the uterine cervix: demonstration of gastric phenotypes. Ultrastruct Pathol 23:375–81CrossRefPubMedGoogle Scholar
  17. 17.
    Mikami Y, Hata S, Fujiwara K, Imajo Y, Kohno I, Manabe T (1999) Florid endocervical glandular hyperplasia with intestinal and pyloric gland metaplasia: worrisome benign mimic of "adenoma malignum". Gynecol Oncol 74:504–11CrossRefPubMedGoogle Scholar
  18. 18.
    Vieth M, Kushima R, Borchard F, Stolte M (2003) Pyloric gland adenoma: a clinico-pathological analysis of 90 cases. Virchows Arch 442:317–321PubMedGoogle Scholar
  19. 19.
    Kushima R, Mukaisho K, Vieth M, Borchard F, Stolte M, Hattori T (2003) Pyloric-gland-type adenomas of the stomach. Stomach and Intestine (Tokyo) 38:1377–1387Google Scholar
  20. 20.
    Kushima R (2004) Pyloric gland adenoma. Pathology and Clinical Medicine 22:634–635Google Scholar
  21. 21.
    Kushima R, Vieth M, Borchard F et al (2006) Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer 9:177–184CrossRefPubMedGoogle Scholar
  22. 22.
    Chen ZM, Scudiere JR, Abraham SC, Montgomery E (2009) Pyloric gland adenoma: an entity distinct from gastric foveolar type adenoma. Am J Surg Pathol 33:186–93CrossRefPubMedGoogle Scholar
  23. 23.
    Remmele W, Stegner HE (1987) Vorschlag zur einheitlichen Definition eines Immunreaktiven Score (IRS) für den immunhistochemischen Östrogenrezeptor-Nachweis (ER-ICA) im Mammakarzinomgewebe. Pathologe 8:138–140PubMedGoogle Scholar
  24. 24.
    Shiroshita H, Watanabe H, Ajioka Y, Watanabe G, Nishikura K, Kitano S (2004) Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC 5AC, M-GGMC, MUC 2 and CD10 stains. Pathol Int 54:311–321CrossRefPubMedGoogle Scholar
  25. 25.
    Kushima R, Jancic S, Hattori T (1993) Association between expression of sialosyl-Tn antigen and intestinalization of gastric carcinomas. Int J Cancer 55:904–8CrossRefPubMedGoogle Scholar
  26. 26.
    Hattori T, Kushima R (2001) Gastric differentiated stomach adenocarcinoma. Pathologe 22:97–104CrossRefPubMedGoogle Scholar
  27. 27.
    Bamba M, Sugihara H, Kushima R, Okada K, Tsukashita S, Hattori T (2001) Time dependent expression of intestinal phenotype in signet ring cell carcinomas of the human stomach. Virchows Arch 438:49–56CrossRefPubMedGoogle Scholar
  28. 28.
    Kushima R, Vieth M (2010) Tubular adenoma of the stomach with special reference to the Japanese criteria and pyloric gland adenoma. Pathologe 31:177–81CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Michael Vieth
    • 1
  • Ryoji Kushima
    • 2
  • Ken-ichi Mukaisho
    • 3
  • Rie Sakai
    • 3
  • T. Kasami
    • 3
  • Takanori Hattori
    • 3
  1. 1.Institute of PathologyKlinikum BayreuthBayreuthGermany
  2. 2.Division of PathologyNational Cancer Center HospitalTokyoJapan
  3. 3.Department of PathologyShiga University of Medical ScienceOtsuJapan

Personalised recommendations